Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VivoSim Labs, INC.ONVO · Entity 8386 | Director | August 07, 2024 | August 09, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VivoSim Labs, INC.
Report date August 07, 2024 · Filed August 09, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 58,821 |
Reported balance
After 2024-08-07 transaction · row 1
1 source rowRow 1 · 2024-08-07 · Grant · Acquired 19,607 · Balance 58,821 F1: The reported securities are represented by restricted stock units, which shall vest on the earlier of August 7, 2025 or the date of the next annual meeting of stockholders held by the Issuer in 2025, subject to acceleration in the event of a change of control. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities are represented by restricted stock units, which shall vest on the earlier of August 7, 2025 or the date of the next annual meeting of stockholders held by the Issuer in 2025, subject to acceleration in the event of a change of control.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 07, 2024 Filed Aug 9, 2024 20:01 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | GrantCommon Stock | 19,607 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-094722 · ownership.xml · nonDerivative · entry 1 Joshi Vaidehi · CIK 0001907496 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,821 F1 · shares: The reported securities are represented by restricted stock units, which shall vest on the earlier of August 7, 2025 or the date of the next annual meeting of stockholders held by the Issuer in 2025, subject to acceleration in the event of a change of control. Read SEC document |
| November 17, 2023 Filed Nov 17, 2023 23:32 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | GrantCommon Stock | 19,607 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-064942 · ownership.xml · nonDerivative · entry 1 Joshi Vaidehi · CIK 0001907496 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,214 F1 · shares: The reported securities are represented by restricted stock units, which shall vest on the earlier of November 17, 2024 or the date of the next annual meeting of stockholders held by the Issuer, subject to acceleration in the event of a change of control. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:07 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | GrantCommon Stock | 19,607 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-035792 · doc4.xml · nonDerivative · entry 1 Joshi Vaidehi · CIK 0001907496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,607 F1 · shares: The reported securities are represented by restricted stock units, which shall vest on the earlier of November 9, 2023 or the date of the next annual meeting of stockholders held by the Issuer, subject to acceleration in the event of a change of control. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 21:35 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $3.47 | $0.00 |
DisclosureSEC source: 0000899243-22-010448 · doc4.xml · derivative · entry 1 Joshi Vaidehi · CIK 0001907496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-03-08 F1 · derivative.exercise_date: The option shares vest and become exercisable over twelve equal quarterly installments measured from March 8, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.